Pleszewskie Centrum Medyczne W Pleszewie Sp. z o.o.

At Pleszewskie Centrum Medyczne W Pleszewie Sp. z o.o., the clinical trial portfolio includes focused oncology research centered on advanced breast cancer. The work spans treatments for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer and locally recurrent inoperable or metastatic triple-negative breast cancer, with studies aimed at improving disease control and extending survival.

• Evaluation of new treatment combinations for advanced breast cancer
• Research in triple-negative breast cancer and HR-positive, HER2-negative breast cancer
• Assessment of progression-free survival and overall treatment benefit

These studies reflect a strong interest in testing whether newer cancer therapies can perform better than established approaches for patients with difficult-to-treat breast malignancies.

The site also supports research in nutritional and metabolic diseases, with a clear focus on type 2 diabetes. The diabetes trial activity is designed to help determine whether a newer insulin-based treatment strategy can provide reliable blood sugar control for people whose diabetes remains inadequately managed.

• Studies in type 2 diabetes
• Comparison of glucose-lowering treatment approaches
• Evaluation of glycaemic control through long-term blood sugar outcomes

This research aims to improve everyday diabetes management by examining how well emerging therapies can maintain stable glucose levels in patients needing more effective control.